![Colin Glenn Begley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Glenn Begley
Fondateur chez
Incendia Therapeutics, Inc.
Profil
Colin Glenn Begley is the founder of Incendia Therapeutics, Inc. He worked as a Non-Executive Director at Oxford BioTherapeutics Ltd., Director at Cyterix Pharmaceuticals, Inc., and Executive Director at Western Australian Institute For Medical Research.
He was also a VP, Global Head-Hematology & Oncology Research at Amgen, Inc. and Chief Scientific Officer at TetraLogic Pharmaceuticals Corp.
He held the position of Head-Human Leukemia Laboratory at The Walter & Eliza Hall Institute of Medical Research and was a Professor at the University of Melbourne.
Dr. Begley earned two doctorate degrees from the University of Melbourne in 1978 and 1986.
Postes actifs de Colin Glenn Begley
| Sociétés | Poste | Début |
|---|---|---|
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Fondateur | - |
Anciens postes connus de Colin Glenn Begley
| Sociétés | Poste | Fin |
|---|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Directeur Technique/Scientifique/R&D | 19/04/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Cyterix Pharmaceuticals, Inc.
 Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes cancer therapeutics | Directeur/Membre du Conseil | - |
The Walter & Eliza Hall Institute of Medical Research
 The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Corporate Officer/Principal | - |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Colin Glenn Begley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Cyterix Pharmaceuticals, Inc.
Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes cancer therapeutics | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Australian Institute For Medical Research | |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
